Multiparametric Cardiac Positron Emission Tomography for Cardiac Allograft Vasculopathy Surveillance After Heart Transplantation: MARINER Trial

多参数心脏正电子发射断层扫描用于心脏移植后心脏同种异体移植血管病变监测：MARINER 试验

• 批准号: 469893
• 负责人: Chih Sharon S
• 金额: $ 69.38万
• 依托单位: University of Ottawa Heart Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-09-01 至 2027-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469893&lang=en
• 关键词: Cardiac Allograft Vasculopathy; Cardiac Positron Emission Tomography (Pet); Clinical Trial; Heart Transplantation; Invasive Coronary Angiography

Heart transplantation is a life-saving treatment for end stage heart disease. After transplant, narrowing of the heart arteries may occur in up to half of patients. This condition, known as cardiac allograft vasculopathy (CAV), can cause the new heart to

心脏移植是一种挽救终末期心脏病生命的治疗方法。移植后，多达一半的患者可能出现心脏动脉狭窄。这种情况被称为心脏同种异体移植血管病变（CAV），会导致新的心脏无法正常工作